Latest filing published 01 Feb 2021 for Aurinia Pharmaceuticals Inc., €81k.
Insider track record
Michael Reuben Hayden: trading record in brief
Michael Reuben Hayden discloses dealings in Aurinia Pharmaceuticals Inc. to SEC (Form 4). The record holds 4 filings, for trades running from 21 February 2018 to 29 January 2021.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 1 February 2021, the filings show an option exercise worth €81k in Aurinia Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Reuben Hayden
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ CA$8.3917.6% of flowCommon SharesTSXSEDI:3671101
- 30,000 shares@ CA$8.0433.8% of flowCommon SharesTSXSEDI:3671100
- 50,000 shares@ CA$6.9248.5% of flowCommon SharesTSXSEDI:3671098
- Common SharesTSXSEDI:3671097
4 of 4 declarations
